Lucira Health, Inc. (LHDX): Price and Financial Metrics Recent IPO


Lucira Health, Inc. (LHDX): $4.85

0.04 (+0.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LHDX Stock Price Chart Interactive Chart >

Price chart for LHDX

LHDX Price/Volume Stats

Current price $4.85 52-week high $37.99
Prev. close $4.81 52-week low $4.23
Day low $4.75 Volume 381,700
Day high $4.91 Avg. volume 1,688,560
50-day MA $6.08 Dividend yield N/A
200-day MA $0.00 Market Cap 187.08M

Lucira Health, Inc. (LHDX) Company Bio


Lucira Health, Inc. produces and distributes medical equipment. The Company offers disposable test kits to detect DNA and RNA of infectious diseases. Lucira Health markets its products in the United States.


LHDX Latest News Stream


Event/Time News Detail
Loading, please wait...

LHDX Latest Social Stream


Loading social stream, please wait...

View Full LHDX Social Stream

Latest LHDX News From Around the Web

Below are the latest news stories about Lucira Health Inc that investors may wish to consider to help them evaluate LHDX as an investment opportunity.

Lucira Health appoints medtech veteran Kevin Collins as CRO

Lucira Health (LHDX) announces Kevin Collins has joined the company as chief revenue officer with global revenue responsibility.Most recently, he was Vice President of International Commercial Operations at Outset Medical (OM).Shares are down 3.19% PM....

Seeking Alpha | May 28, 2021

LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced medtech veteran Kevin Collins has joined the company as Chief Revenue Officer with global revenue responsibility.

Yahoo | May 28, 2021

Is Lucira Health a Good Stock to Buy Right Now?

Shares of Lucira Health (NASDAQ: LHDX) exploded out of the gate when the company made its stock market debut in February. Lucira Health's over-the-counter COVID-19 tests racked up millions of dollars in sales during the first three months of 2021, leading some investors to wonder if this beaten-down stock can bounce back.

Yahoo | May 25, 2021

Lucira Health to Participate in William Blair 41st Annual Growth Stock Conference

EMERYVILLE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will be participating in the William Blair 41st Annual Growth Stock Conference. Lucira Health’s management is scheduled to participate in the conference on Wednesday, June 2, 2021, at 10:40 a.m. PT / 1:40 p.m. ET. Interested parties can access the live and archived webcast at ir.lucirahealth.com. About Lucira HealthLucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform pro...

Yahoo | May 25, 2021

Lucira Health, Inc. (LHDX) Q1 2021 Earnings Call Transcript

Earlier today, Lucira Health received -- released financial results for the first quarter ended March 31, 2021. Joining me today on today's call are Erik Engelson, president and chief executive officer; and Dan George, chief financial officer.

Yahoo | May 17, 2021

Read More 'LHDX' Stories Here

LHDX Price Returns

1-mo 3.19%
3-mo -67.77%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6902 seconds.